Momose Mitsuru, Babazono Tetsuya, Kondo Chisato, Kobayashi Hideki, Nakajima Takatomo, Kusakabe Kiyoko
Department of Radiology, Tokyo Women's Medical University, School of Medicine, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan.
Eur J Nucl Med Mol Imaging. 2009 Aug;36(8):1315-21. doi: 10.1007/s00259-009-1110-4. Epub 2009 Mar 19.
Diabetic patients with chronic kidney disease (CKD) frequently develop cardiac events within several years of the initiation of haemodialysis. The present study assesses the prognostic significance of stress myocardial ECG-gated perfusion imaging (MPI) in patients with diabetic CKD requiring haemodialysis.
Fifty-five asymptomatic patients with diabetic stage V CKD and no history of heart disease scheduled to start haemodialysis were enrolled in this study (56 +/- 11 years old; 49 with type 2 diabetes mellitus). All patients underwent (201)Tl stress ECG-gated MPI 1 month before or after the initiation of haemodialysis to assess myocardial involvement. We evaluated SPECT images using 17-segment defect scores graded on a 5-point scale, summed stress score (SSS) and summed difference scores (SDS). The patients were followed up for at least 2 years (42 +/- 15 months) to determine coronary intervention (CI) and heart failure (HF) as soft events and acute myocardial infarction (AMI) and all causes of deaths as hard events.
The frequencies of myocardial ischaemia, resting perfusion defects, low ejection fraction and left ventricular (LV) dilatation were 24, 20, 29 and 49%, respectively. Ten events (18%) developed during the follow-up period including four CI, one HF, one AMI and four sudden deaths. Multivariate Cox analysis selected SDS (p = 0.0011) and haemoglobin A(1c) (HbA(1c)) (p = 0.0076) as independent prognostic indicators for all events.
Myocardial ischaemia, in addition to glycaemic control, is a strong prognostic marker for asymptomatic patients with diabetic CKD who are scheduled to start haemodialysis. Stress MPI is highly recommended for the management and therapeutic stratification of such patients.
患有慢性肾脏病(CKD)的糖尿病患者在开始血液透析后的几年内经常发生心脏事件。本研究评估了应激心肌心电图门控灌注成像(MPI)对需要血液透析的糖尿病CKD患者的预后意义。
本研究纳入了55例无症状的糖尿病Ⅴ期CKD患者,这些患者无心脏病史且计划开始血液透析(年龄56±11岁;49例为2型糖尿病)。所有患者在开始血液透析前或后1个月接受(201)铊应激心电图门控MPI,以评估心肌受累情况。我们使用17节段缺损评分(采用5分制分级)、总应激评分(SSS)和总差异评分(SDS)来评估单光子发射计算机断层扫描(SPECT)图像。对患者进行至少2年的随访(42±15个月),以确定冠状动脉介入治疗(CI)和心力衰竭(HF)作为软性事件,以及急性心肌梗死(AMI)和所有死因作为硬性事件。
心肌缺血、静息灌注缺损、低射血分数和左心室(LV)扩张的发生率分别为24%、20%、29%和49%。随访期间发生了10起事件(18%),包括4例CI、1例HF、1例AMI和4例猝死。多因素Cox分析选择SDS(p = 0.0011)和糖化血红蛋白(HbA1c)(p = 0.0076)作为所有事件的独立预后指标。
除血糖控制外,心肌缺血是计划开始血液透析的无症状糖尿病CKD患者的一个强有力的预后标志物。强烈建议对这类患者进行应激MPI检查,以进行管理和治疗分层。